Human hand and robot hand touching fingers

iStock

Revvity to Unveil New Cell Imaging Software at SLAS2025

Revolutionary solution for cellular imaging for accelerating drug discovery and development

| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and Signals Image Artist™ software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis. This significant advancement expands the possibilities for understanding cellular behaviors and disease mechanisms. The Phenologic.AI offering provides scalable, efficient, and objective analysis and can be integrated with Revvity Signals Research Suite™ to provide more in-depth data analytics.

Complementing this launch, Revvity will also introduce other notable products, including the latest Harmony™ 5.3 software, which simplifies data management for high-content imaging and analysis, providing faster and more intuitive data handling.

Interested in lab tools and techniques?

Subscribe to our free Lab Tools & Techniques Newsletter.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

Attendees can explore these technologies and more at Revvity’s booth (#1318), where over 40 products from its life sciences portfolio will be showcased. These include solutions for assay development, automation, cellular research, liquid handling, flow cytometry, and reagents, all designed to accelerate innovation and efficiency across drug discovery and development. Revvity’s strategy centers on supporting scientists in overcoming research challenges with transformative technologies.

Kevin Quick, vice president of platforms, life sciences, stated, "SLAS is a great opportunity to showcase our most innovative technologies and celebrated brands. Our strategy and offerings are designed to support scientists in accelerating discoveries and expediting progress from basic research into clinical development.”

-Note: This news release was originally published on the Revvity website. As it has been republished, it may deviate from our style guide.

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - January/February 2025

Energizing Leadership in Action

The science-backed behaviors that help leaders inspire thriving teams and organizations

Lab Manager January/February 2025 Cover Image